SBIO vs. BBP
Compare and contrast key facts about ALPS Medical Breakthroughs ETF (SBIO) and Virtus LifeSci Biotech Products ETF (BBP).
SBIO and BBP are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. Both SBIO and BBP are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
SBIO vs. BBP - Performance Comparison
Loading graphics...
SBIO vs. BBP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 3.20% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
BBP Virtus LifeSci Biotech Products ETF | 4.77% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -13.95% | 24.07% |
Returns By Period
In the year-to-date period, SBIO achieves a 3.20% return, which is significantly lower than BBP's 4.77% return. Over the past 10 years, SBIO has underperformed BBP with an annualized return of 9.75%, while BBP has yielded a comparatively higher 12.85% annualized return.
SBIO
- 1D
- 0.99%
- 1M
- 3.89%
- YTD
- 3.20%
- 6M
- 36.23%
- 1Y
- 95.78%
- 3Y*
- 26.37%
- 5Y*
- 1.76%
- 10Y*
- 9.75%
BBP
- 1D
- 0.80%
- 1M
- -0.93%
- YTD
- 4.77%
- 6M
- 17.96%
- 1Y
- 47.40%
- 3Y*
- 19.33%
- 5Y*
- 9.54%
- 10Y*
- 12.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SBIO vs. BBP - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than BBP's 0.79% expense ratio.
Return for Risk
SBIO vs. BBP — Risk / Return Rank
SBIO
BBP
SBIO vs. BBP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO | BBP | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.92 | 1.78 | +1.15 |
Sortino ratioReturn per unit of downside risk | 3.57 | 2.44 | +1.13 |
Omega ratioGain probability vs. loss probability | 1.45 | 1.30 | +0.15 |
Calmar ratioReturn relative to maximum drawdown | 5.66 | 3.20 | +2.46 |
Martin ratioReturn relative to average drawdown | 19.94 | 11.83 | +8.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SBIO | BBP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.92 | 1.78 | +1.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 0.37 | -0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.47 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.40 | -0.17 |
Correlation
The correlation between SBIO and BBP is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
SBIO vs. BBP - Dividend Comparison
Neither SBIO nor BBP has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
Drawdowns
SBIO vs. BBP - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than BBP's maximum drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for SBIO and BBP.
Loading graphics...
Drawdown Indicators
| SBIO | BBP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -44.32% | -18.74% |
Max Drawdown (1Y)Largest decline over 1 year | -15.08% | -13.38% | -1.70% |
Max Drawdown (5Y)Largest decline over 5 years | -53.67% | -38.28% | -15.39% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | -44.32% | -18.74% |
Current DrawdownCurrent decline from peak | -13.79% | -3.12% | -10.67% |
Average DrawdownAverage peak-to-trough decline | -28.70% | -12.16% | -16.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.28% | 3.62% | +0.66% |
Volatility
SBIO vs. BBP - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 12.61% compared to Virtus LifeSci Biotech Products ETF (BBP) at 10.64%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than BBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SBIO | BBP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.61% | 10.64% | +1.97% |
Volatility (6M)Calculated over the trailing 6-month period | 22.09% | 18.02% | +4.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.43% | 27.02% | +6.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.55% | 26.22% | +7.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.34% | 27.51% | +5.83% |